Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

ClickSlim vs FMmeds

ClickSlim
Graded #491

Lower grade

vs+13.300000000000004
FMmeds
Graded #257

Higher grade

The verdict

FMmeds takes it — 63.2/100 to 49.9/100.

FMmeds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. FMmeds is a Manhattan Beach-based DTC telehealth platform selling compounded semaglutide and tirzepatide co-formulated with vitamin B12, with no membership fee and a free initial visit billed only on approval.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueFMmeds +14
32
46
Dose & formulationFMmeds +20
52
72
Clinical oversightFMmeds +10
60
70
Labs & monitoringFMmeds +1
52
53
FulfillmentFMmeds +32
65
97
Contract termsClickSlim +2
49
47
ClickSlim · left barFMmeds · right bar

The numbers

MetricClickSlimFMmeds
WeighScore49.9/10063.2/100
GradeCC
Scorecard rank#491#257
SemaglutideNot disclosed$225/mo (all doses, compounded)
Tirzepatide$349/mo (compounded)$265/mo (all doses, compounded)
CoverageCoverage not publishedAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
ClickSlim

Graded #491 · C

Strengths

  • Both the introductory and the ongoing price are published, so the step-up is visible before you buy
  • States plainly that it is not a pharmacy or a drug manufacturer and that medication is dispensed by a licensed third party
  • Text support line published with stated hours
  • LegitScript certification verified against the issued seal, not just the badge

Where it loses points

  • Its own NAD+ product card is labelled CONTAINS TIRZEPATIDE, which contradicts the product it is selling
  • No state list is published; the site says only that services are available in most States
  • Prices are among the highest in the category, at $349 ongoing for tirzepatide
  • Registered at a Sheridan, Wyoming suite address commonly used as a mail-forwarding and registered-agent address
  • Terms set arbitration in San Diego under California law while the company address is in Wyoming
FMmeds

Graded #257 · C

Strengths

  • All 50 states plus DC covered, stated in the Terms
  • Operating LLC and full Manhattan Beach, CA address disclosed
  • Named 503A pharmacy partner (Manifest Pharmacy, Greer SC)
  • Aggressive 12-month pricing — semaglutide $95/mo and tirzepatide $145/mo, at the low end of the market
  • Flat pricing across all dose strengths — no dose-escalation surcharge

Where it loses points

  • Compounded only — no FDA-approved Wegovy, Ozempic, Mounjaro, or Zepbound
  • Publishes the FDA compounded-medication disclaimer (medication is not FDA-approved)
  • Clinical network not separately named
  • LegitScript Certified, but the specific ID isn't shown
  • FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard